Market Cap
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd Market Capitalization:
CN¥6.95 Billion
CNY as of Jan. 1, 2024
US$977.5 Million
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd Main Stock Listing
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—Specialty & Generic
| Company | Market Cap (USD) |
|---|---|
Zoetis Inc.
|
$89.09 B |
MERCK Kommanditgesellschaft auf Aktien
|
$67.64 B |
Takeda Pharmaceutical Company Limited
|
$47.71 B |
Haleon plc
|
$38.90 B |
|
PPD, Inc.
|
$16.58 B |
Sector: Healthcare
| Company | Market Cap (USD) |
|---|---|
|
Lilly
|
$586.39 B |
|
UnitedHealth Group
|
$504.47 B |
Novo Nordisk
|
$461.52 B |
|
Johnson & Johnson
|
$387.50 B |
|
Merck
|
$296.51 B |
Top 1-year algo backtest: +313.24%
$10,000 in May 2023 would now be $41,324 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd Categories
China
languages
Healthcare
languages
Drug Manufacturers—Specialty & Generic
China Healthcare
China Drug Manufacturers—Specialty & Generic
Stocks & Indices
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd has the following listings and related stock indices.
Stock: SSE: 688505
Stock: HKEX: 1349
What is a company's market capitalization?
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.